Gene-based interventions to modify aging processes
Gliomas account for ∼80% of primary malignant brain tumors. Many CNS WHO grade 2-3 and some grade 4 gliomas harbor mutant isocitrate dehydrogenase 1 (mIDH1), which causes a gain-of-function mutation (IDH1 R132H) leading to the …
This review examines 'partial reprogramming'—a technique that temporarily activates rejuvenation factors to reverse aging hallmarks in cells and tissues without turning them into cancer-prone stem cells. Early evidence suggests it can restore tissue function and …
Researchers developed a gene therapy that protects telomeres (the caps on DNA) in heart cells, preventing damage signals that trigger mitochondrial dysfunction and heart failure. In mouse models and human cell cultures, this approach restored …
Researchers discovered that mutant huntingtin protein in Huntington's disease forms dynamic structures around the cell's Golgi apparatus (the protein-packaging organelle), disrupting its normal function. This 'Golgipathy' mechanism reveals why current therapies fail and suggests new …
Scientists developed a technology that uses electromagnetic fields to remotely activate specific genes in living mice with precise timing and location control. They tested it by partially reversing aging processes, modeling Alzheimer's disease, and treating …
Researchers built a precise 'immune aging clock' from blood cell data of 230 people and discovered that a protein called RUNX1 acts as a brake on immune cell aging. When they restored RUNX1 in old …
This review examines gene therapy's potential to combat aging by targeting fundamental aging processes across multiple organ systems, citing encouraging preclinical results in nervous, muscular, circulatory, and immune systems. However, the authors emphasize that translating …
Chemoresistance remains the primary cause of cancer treatment failure, yet current understanding remains fragmented across isolated mechanistic studies. This review provides a unified framework linking tumor microenvironment (TME) signaling, epigenetic reprogramming, and nanotherapeutic intervention as …
The decline of organ function during aging limits healthspan. Despite the potential of lifestyle interventions to improve health, sustained maintenance of healthspan is challenging, and no gerotherapeutic drugs have been approved. Here, we demonstrated that …
Aging is the primary risk factor for most chronic diseases, and the global rise in aging populations presents an escalating challenge due to functional decline and multimorbidity. Gene therapy provides a versatile framework for modulating …
Aging affects virtually all organs and biological processes, and age-related diseases remain the leading causes of death worldwide. Genetic factors play a central role in modulating lifespan, and discoveries in the genetic manipulation of the …
This study reveals that a key growth factor called IGF-1 is essential for the rejuvenating effects of young blood on aging brains. When old mice shared circulation with young mice, their brain blood vessels improved—but …
Chimeric antigen receptor (CAR)-T cell therapy has shown success in hematologic malignancies but remains limited in solid tumors due to poor persistence, migration, and tumor microenvironment-induced exhaustion. In an investigator-initiated trial in relapsed/refractory ovarian cancer, …
Researchers developed a method to rejuvenate aging mesenchymal stem cells (MSCs) by temporarily expressing three genes via a non-integrating virus, then removing the virus. The rejuvenated cells showed extended lifespan, restored telomeres, and maintained their …
This is a curated introductory post for r/longevity that distinguishes legitimate aging biology research from quackery, providing structured access to academic papers, presentations, and university labs studying the biology of aging. The post establishes the …
Researchers used specially designed lipid nanoparticles to deliver reprogramming genes (OSK) directly to liver cells in mice with fibrosis, successfully converting scarred cells back to a regenerative state. This proof-of-concept study suggests mRNA-based cellular rejuvenation …
Researchers identified DMTF1, a transcription factor, as potentially therapeutic for reversing age-related decline in neural stem cell proliferation caused by telomere shortening. The mechanism involves DMTF1 regulating SWI/SNF chromatin complexes to activate E2F genes, a …
A 2026 study by Shenhar and Alon claims genetics determine 50–55% of human lifespan—roughly double previous estimates of 15–30%—by filtering out accidental deaths from twin data. The finding suggests aging is a genetically regulated process …
Researchers used a gene therapy technique to partially "reprogram" neurons that store memories in aged mice and Alzheimer's disease models, reversing signs of aging in those cells and restoring learning and memory to young-animal levels. …
This review synthesizes evidence that activating Hedgehog signaling—a developmental pathway—may counteract hallmarks of aging like stem cell exhaustion and chronic inflammation across brain, liver, heart, and other tissues. While preclinical results are promising, the authors …